One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Accesshttps://doi.org/10.1182/blood.v130.suppl_1.2777.2777
Copy DOI Journal: Blood |  Publication Date: Jun 25, 2021 |
Affiliation: LMU Klinikum, National and Kapodistrian University of Athens, Ankara University, Tel Aviv University, Sheba Medical Center, Sungkyunkwan University, Samsung Medical Center, Bayer (United States), University of Bordeaux, Norton Healthcare, Hôpital Claude Huriez, Semmelweis University, Humanitas University, Kemerovo Cardiology Center, University Hospital Münster, Cambridge University Hospitals NHS Foundation Trust, Helsinki University Hospital, Bayer (Germany), Hôpital Maisonneuve-Rosemont, University of BolognaUpdated Safety and Efficacy from the Copanlisib CHRONOS-1 Trial in Patients with Relapsed or Refractory Indolent B-Cell Lymphoma: Low Incidence of Late-Onset Severe Toxicities
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
